Restoring miR-16 also re-sensitised MPM cells to pemetrexed and gemcitabine and the intravenous administration of miR-16 in nanocells with epidermal growth factor receptor (EGFR) specific antibodies, inhibited tumour growth in mice [75]. Here, EGFR is linked to neoplasm.